The Suicide Gene Therapy Challenge: How to Improve a Successful Gene Therapy Approach
Open Access
- 1 July 2007
- journal article
- review article
- Published by Elsevier in Molecular Therapy
- Vol. 15 (7) , 1248-1252
- https://doi.org/10.1038/sj.mt.6300190
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Lentiviral Vectors for T-cell Suicide Gene Therapy: Preservation of T-cell Effector Function After Cytokine-mediated TransductionMolecular Therapy, 2007
- 1107. Gene Therapy Clinical Trials for Relapsed Leukemia with Infusions of the Suicide-Gene Transduced Donor Lymphocytes in JapanMolecular Therapy, 2006
- Retroviral vector insertions in T-lymphocytes used for suicide gene therapy occur in gene groups with specific molecular functionsBone Marrow Transplantation, 2006
- Pharmacologically regulated Fas-mediated death of adoptively transferred T cells in a nonhuman primate modelBlood, 2004
- IL-7 surface-engineered lentiviral vectors promote survival and efficient gene transfer in resting primary T lymphocytesBlood, 2003
- HIV-1 Integration in the Human Genome Favors Active Genes and Local HotspotsCell, 2002
- Elimination of the Truncated Message from the Herpes Simplex Virus Thymidine Kinase Suicide GeneMolecular Therapy, 2001
- Systematic analysis of clinically applicable conditions leading to a high efficiency of transduction and transgene expression in human T cellsThe Journal of Gene Medicine, 2001
- Retrovirus-Mediated Gene Transfer in Primary T Lymphocytes: Influence of the Transduction/Selection Process and ofex VivoExpansion on the T Cell Receptor β Chain Hypervariable Region RepertoireHuman Gene Therapy, 2000
- “Suicide” gene for the control of graft-versus-host diseaseCurrent Opinion in Hematology, 1998